CA Patent

CA3226446A1 — Systems, devices and methods for intradermal or subdermal fluid delivery

Assigned to Acom Labs Inc · Expires 2023-01-26 · 3y expired

What this patent protects

Systems, devices, and methods for intradermal or subdermal fluid delivery via a microneedle are provided. A delivery system can include an injector, fluid-filled cartridge or syringe, and a needle. A cartridge or syringe can be compatibly coupled with an injector device such that…

USPTO Abstract

Systems, devices, and methods for intradermal or subdermal fluid delivery via a microneedle are provided. A delivery system can include an injector, fluid-filled cartridge or syringe, and a needle. A cartridge or syringe can be compatibly coupled with an injector device such that the injector device is capable of ejecting fluid out of the cartridge and though the needle. Fluid delivery systems can be utilized in a number of applications, including medications and supplements for the skin.

Drugs covered by this patent

Patent Metadata

Patent number
CA3226446A1
Jurisdiction
CA
Classification
—
Expires
2023-01-26
Drug substance claim
No
Drug product claim
No
Assignee
Acom Labs Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.